2019 ASCO Annual Meeting

2019 ASCO Annual Meeting

INTERVIEW WITH SILKE GILLESSEN
Preview of the Advanced Prostate Cancer Consensus Conference 2019 (APCCC)

VIEW ALL ADV PROSTATE VIDEOS

2019 ASCO Annual Meeting

2019 ASCO Annual Meeting

INTERVIEW WITH JONATHAN ROSENBERG
Results from CALGB 90601 in Metastatic Urothelial Carcinoma

VIEW ALL ADV BLADDER VIDEOS

2019 ASCO Annual Meeting

2019 ASCO Annual Meeting

INTERVIEW WITH CORA STERNBERG
SAUL Trial Data: Real World Experience of Atezolizumab in Carcinomas of the Urinary Tract

VIEW ALL UTUC VIDEOS

2019 ASCO Annual Meeting

2019 ASCO Annual Meeting

INTERVIEW WITH TANYA DORFF
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

VIEW ALL mHSPC VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Featured Videos

#AUA14 - Direct endoscopic visualization with combined ultrasound guided access during percutaneous nephrolithotomy – a feasibility study and comparison to conventional cohort - Session Highlights

ORLANDO, FL USA (UroToday.com) - Access in PCNL cases remains challenging. The study group presented a novel approach combining direct ureteroscopic visualization of access location with ultrasound guidance. They aimed to compare outcomes in patients with US-guided percutaneous renal access to conventional fluoroscopic guided access.

auaA ureterosope was placed in the kidney without using fluoroscopy and the optimal calyx for puncture was chosen. Under percutaneous US, the selected calyx was identified and punctured. A wire was then advanced into the calyx and pulled into the ureter. Balloon, sheath, and nephrostomy tube placement were all performed under direct ureteroscopic guidance. The researchers compared perioperative parameters of 10 consecutive patients (group I) with this novel technique to 20 patients who had undergone conventional fluoroscopic access (group II). Operative time, fluoroscopy time, EBL, stone-free rates, hospital stay, and complications were evaluated.

There was no difference in operative time (p=0.749), EBL (p=0.880), stone-free rates (p=0.377), mean hospital stay (p=0.155), or complication rates (p=0.559) between the two groups. But the study group showed a significant reduction in fluoroscopy time to achieve access (4.6 vs 790 sec; p < 0.001) and total fluoroscopy time (10.6 vs 859 sec; p < 0.001) when using this novel technique.

The authors demonstrate the feasibility of combined US and ureteroscopic assisted access for PCNL, including tract dilation and tube placement under direct endoscopic visualization. This novel approach results in a > 90% reduction in fluoroscopy time.

Presented by Javier Arenas, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Loma Linda, CA USA

Written by Achim Lusch, MD, University of California (Irvine), and medical writer for UroToday.com

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe